ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,963Medicare Part D Prescriptions Filled, Including Refills

Rank: 230 out of 972

$524K Total Retail Price of All Prescriptions

Rank: 293 out of 972

438 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
12% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 438 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 438 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

4% of this provider’s 9,698 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
AMLODIPINE BESYLATE 430 408 1 4
LEVOTHYROXINE SODIUM 400 367 2 3
LOSARTAN POTASSIUM 379 319 3 17
OMEPRAZOLE 313 286 4 5
SIMVASTATIN 296 268 5 2
LISINOPRIL 295 271 6 1
HYDROCODONE-ACETAMINOPHEN 282 237 S3 7 6
LOVASTATIN 274 260 8 22
CARVEDILOL 241 215 9 21
CITALOPRAM HBR 236 217 10 19
ATORVASTATIN CALCIUM 214 204 11 11
METFORMIN HCL 202 188 12 8
FUROSEMIDE 201 179 13 7
METOPROLOL TARTRATE 198 189 14 9
TERAZOSIN HCL 190 153 15 120
FLUTICASONE PROPIONATE 183 162 16 31
TRAZODONE HCL 147 128 17 35
GLYBURIDE 132 127 R 18 70
ALENDRONATE SODIUM 129 118 19 27
PRAVASTATIN SODIUM 124 119 20 20
SPIRONOLACTONE 116 84 21 54
METOPROLOL SUCCINATE 115 103 22 16
CRESTOR 104 97 23 33
SYNTHROID 104 96 23 51
DIOVAN 100 86 25 48
AMITRIPTYLINE HCL 99 95 R 26 58
HYDROCHLOROTHIAZIDE 99 93 26 10
SERTRALINE HCL 95 79 28 25
POTASSIUM CHLORIDE 92 80 29 13
GABAPENTIN 91 75 30 14
CLOPIDOGREL 90 83 31 37
PANTOPRAZOLE SODIUM 88 70 32 41
CIPROFLOXACIN HCL 85 84 33 63
LYRICA 84 72 34 113
TRAMADOL HCL 81 63 35 15
CLONIDINE HCL 81 81 35 57
ISOSORBIDE MONONITRATE ER 81 72 35 43
WARFARIN SODIUM 78 62 38 12
TAMSULOSIN HCL 75 74 39 29
PREMARIN 71 52 R 40 153
ATENOLOL 71 55 40 18
DONEPEZIL HCL 70 70 42 26
OXYBUTYNIN CHLORIDE 70 52 42 97
RANITIDINE HCL 69 54 44 24
ZETIA 67 64 45 79
MELOXICAM 64 58 46 36
VENLAFAXINE HCL ER 64 43 46 107
ALLOPURINOL 61 61 48 28
NEXIUM 58 56 49 30
FENOFIBRATE 58 42 49 66
GEMFIBROZIL 56 48 51 93
SPIRIVA 56 56 51 56
TRANDOLAPRIL 55 55 53 333
PAROXETINE HCL 54 54 54 64
POLYETHYLENE GLYCOL 3350 53 43 55 67
PLAVIX 52 47 56 55
CYCLOBENZAPRINE HCL 50 34 R 57 53
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 7, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.